Akebia Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference
Akebia Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference
CAMBRIDGE, Mass., Nov. 25, 2024 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John Butler, Chief Executive Officer, will participate in a Fireside Discussion at the 36th Annual Piper Sandler Healthcare Conference on Tuesday, December 3rd at 10:30 AM EST.
美國馬薩諸塞州劍橋市，2024年11月25日 /PRNewswire/ -- akebia therapeutics公司（納斯達克：AKBA）是一家生物製藥公司，旨在改善受到腎病影響的人的生活，今天宣佈首席執行官約翰·巴特勒將參加於12月3日（星期二）上午10:30（東部標準時間）舉行的第36屆派傑投資醫療保健會議的爐邊討論。
A webcast of the presentation can be accessed through the "Investors" section of Akebia's website at for 6 months following the conference.
演講的網絡直播可以通過akebia網站的「投資者」部分訪問，可在會議後6個月內觀看。
The Piper Sandler Healthcare Conference will take place December 3-5, 2024 in New York.
派傑投資醫療保健會議將於2024年12月3日至5日在紐約舉行。
About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at , which does not form a part of this release.
關於Akebia Therapeutics
Akebia Therapeutics，Inc.是一家完全整合的生物製藥公司，旨在改善腎臟疾病患者的生活。Akebia成立於2007年，總部位於馬薩諸塞州劍橋市。要了解更多信息，請訪問我們的網站。
Akebia Therapeutics Contact
Mercedes Carrasco
[email protected]
Akebia Therapeutics聯繫方式
Mercedes Carrasco
[email protected]
SOURCE Akebia Therapeutics, Inc.
SOURCE Akebia Therapeutics，Inc.
